The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Merck has agreed to settle pending Vioxx claims for a total of $4.85 billion.

The settlement is an offer of settlement to individual plaintiffs, provided they can show “1) objective medical proof of either a heart attack or ischemic stroke; (2) documented receipt of at least 30 Vioxx pills; and (3) receipt of pills in sufficient number and proximity to the event to support a presumption that the patient was still taking the pills within 14 days before the heart attack or stroke.”

If 85% of the plaintiffs in each of the strongest categories do not accept the settlement, then the offer is void.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest